Acurion
PrivateLast Round
Seed
Apr 2, 2026
Total Funding Raised
$4.3M
Company Overview
Acurion is a precision oncology company that provides an AI-powered platform, OncoGaze™, to analyze pathology images for rapid cancer biomarker detection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acurion Comps
Public and private peers based on sector, stage, and business model.
Acurion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 2, 2026 |
Key People
Founding team and executive leadership
Acurion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mesa Verde Venture Partners | Seed |
| TK & Partners | Seed |
| Bootstrap Venture Partners | Seed |
| National Foundation for Cancer Research | Seed |
| Asian Fund for Cancer Research | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
$4.3M raised in Seed round.
- Oct 16, 2025
Grew 33% QoQ from 9 to 12 employees.
Acurion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acurion's valuation, stock price, and market status.
